Bio-Thera Solutions Ltd - Class A

NEW
SHSE:688177 (China)   Class A
¥ 17.41 +0.14 (+0.81%) Sep 8
At Loss
P/B:
58.03
Market Cap:
¥ 7.21B ($ 1.07B)
Enterprise V:
¥ 7.65B ($ 1.14B)
Volume:
234.14M
Avg Vol (2M):
4.31M
Trade In:
Volume:
234.14M
At Loss
Avg Vol (2M):
4.31M

Business Description

Description
Bio-Thera Solutions Ltd is engaged in Research and development and production of inventive drugs and biosimilars.
Name Current Vs Industry Vs History
Cash-To-Debt
0.44
Equity-to-Asset
0.05
Debt-to-Equity
7.25
Debt-to-EBITDA
-2.05
Piotroski F-Score
6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
-0.5
Distress
Grey
Safe
Beneish M-Score
-3.19
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI
16.73
9-Day RSI
29.17
14-Day RSI
37.16
3-1 Month Momentum %
6.43
6-1 Month Momentum %
-17.99
12-1 Month Momentum %
-44.18

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
0.65
Quick Ratio
0.44
Cash Ratio
0.23
Days Inventory
586.13
Days Sales Outstanding
59.06
Days Payable
387.57

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield %
-1.18
Name Current Vs Industry Vs History
Gross Margin %
80.23
Operating Margin %
-42.84
Net Margin %
-45.36
EBITDA Margin %
-43.4
FCF Margin %
-16.29
OCF Margin %
6.3
ROE %
-128.11
ROA %
-19.58
ROIC %
-17.84
3-Year ROIIC %
14.47
ROC (Joel Greenblatt) %
-40.17
ROCE %
-46.74
Years of Profitability over Past 10-Year
1
Name Current Vs Industry Vs History
PS Ratio
7.11
PB Ratio
58.03
Price-to-Operating-Cash-Flow
113.79
EV-to-EBIT
-17.56
EV-to-EBITDA
-17.56
EV-to-Revenue
7.62
EV-to-FCF
-46.78
Price-to-GF-Value
0.52
Earnings Yield (Greenblatt) %
-5.69
FCF Yield %
-2.29
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Bio-Thera Solutions Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil ¥) 1,011.877
EPS (TTM) (¥) -1.11
Beta 1.3729
3-Year Sharpe Ratio -0.24
3-Year Sortino Ratio -0.35
Volatility % 19.08
14-Day RSI 37.16
14-Day ATR (¥) 0.894922
20-Day SMA (¥) 19.566
12-1 Month Momentum % -44.18
52-Week Range (¥) 15.57 - 33.56
Shares Outstanding (Mil) 414.08

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Bio-Thera Solutions Ltd Filings

Filing Date Document Date Form
No Filing Data

Bio-Thera Solutions Ltd Stock Events

Financials Calendars
Event Date Price (¥)
No Event Data

Bio-Thera Solutions Ltd Frequently Asked Questions

What is Bio-Thera Solutions Ltd(SHSE:688177)'s stock price today?
The current price of SHSE:688177 is ¥17.41. The 52 week high of SHSE:688177 is ¥33.56 and 52 week low is ¥15.57.
When is next earnings date of Bio-Thera Solutions Ltd(SHSE:688177)?
The next earnings date of Bio-Thera Solutions Ltd(SHSE:688177) is .
Does Bio-Thera Solutions Ltd(SHSE:688177) pay dividends? If so, how much?
Bio-Thera Solutions Ltd(SHSE:688177) does not pay dividend.

Articles on Bio-Thera Solutions Ltd

No articles.